One of Kansas City’s most under the radar startups is scaling up amid COVID-19 — thanks in part to a share of $250 thousand in non-dilutive funding from a Los Angeles-based accelerator and FDA sponsored pediatric device consortia.
“When COVID hit, one of the things I took from that was, ‘When you’re not selling, your process better be impeccable,’” said Chris Mathia, CEO of Innara Health, the healthtech startup behind the NTrainer — the only FDA approved solution for improving oral coordination in premature babies.
Image: Chris Mathia, Innara Health
{iframe}https://www.startlandnews.com/2020/09/innara-health/{/iframe}